We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

88 hedge funds and large institutions have $12.6M invested in Definium Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

879% more call options, than puts

Call options by funds: $9.78M | Put options by funds: $999K

13% more capital invested

Capital invested by funds: $11.1M → $12.6M (+$1.41M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.12% less ownership

Funds ownership: 13.48% → 10.36% (-3.1%)

15% less funds holding

Funds holding: 104 → 88 (-16)

27% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 22

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
88
Holders Change
-16
Holders Change %
-15.38%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
16
Reduced
22
Closed
19
Calls
$9.78M
Puts
$999K
Net Calls
+$8.78M
Net Calls Change
+$1.56M

Top Buyers

1
Two Sigma Investments
Two Sigma Investments
New York
+$447K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$220K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$194K
4
Renaissance Technologies
Renaissance Technologies
New York
+$185K
5
State Street
State Street
Massachusetts
+$76.8K

Top Sellers

1
MFG
Merit Financial Group
Georgia
-$1.19M
2
Millennium Management
Millennium Management
New York
-$549K
3
Goldman Sachs
Goldman Sachs
New York
-$236K
4
Citadel Advisors
Citadel Advisors
Florida
-$205K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
CWA
51
Clearview Wealth Advisors
Oregon
$209 – – –
HCM
52
Hollencrest Capital Management
California
$209 – – –
WIM
53
Westside Investment Management
California
$209 – – –
Northwestern Mutual Wealth Management
54
Northwestern Mutual Wealth Management
Wisconsin
$209 +$146 +44 +200%
US Bancorp
55
US Bancorp
Minnesota
$209 +$219 +66 New
TCM
56
Tradewinds Capital Management
Washington
$169 -$336 -101 -66%
GI
57
Gradient Investments
Minnesota
$120 +$60 +18 +90%
PMFA
58
Plante Moran Financial Advisors
Michigan
$114 – – –
CAM
59
Chesapeake Asset Management
New York
$104 +$110 +33 New
GEA
60
Glen Eagle Advisors
New Jersey
$95 – – –
HWM
61
HighMark Wealth Management
Minnesota
$92 -$86 -26 -47%
AAP
62
Arax Advisory Partners
Colorado
$89 – – –
RF
63
Robbins Farley
New Hampshire
$89 – – –
AWM
64
Avior Wealth Management
Nebraska
$76 – – –
FCA
65
FinTrust Capital Advisors
South Carolina
$73 – – –
PP
66
Pacifica Partners
Canada
$58 – – –
NC
67
NewSquare Capital
Pennsylvania
$54 – – –
NA
68
NewEdge Advisors
Louisiana
$48 – – –
SIC
69
SJS Investment Consulting
Ohio
$45 – – –
CB
70
CNB Bank
Pennsylvania
$32 – – –
FWM
71
Focused Wealth Management
New York
$32 – – –
HI
72
Harbour Investments
Wisconsin
$32 – – –
JWM
73
Janiczek Wealth Management
Colorado
$32 – – –
ASN
74
Advisory Services Network
Georgia
$29 -$53 -16 -64%
BC
75
Belmont Capital
California
$19 – – –
1 2
3
4

DFTX Hedge Fund Activity: Q1 2023 in Review

88 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q1 2023, worth a combined $12.6M — up 13% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of DFTX and 8 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 16 added.

The largest buyer was Two Sigma Investments, adding an estimated $447K. The largest seller was Merit Financial Group, exiting entirely with an estimated $1.19M sold.

  • 88 institutional investors held Definium Therapeutics (DFTX) as of Q1 2023, down from 104 in Q4 2022.
  • Funds reported $12.6M of Definium Therapeutics stock for Q1 2023, up 13% quarter-over-quarter.
  • 8 funds opened new Definium Therapeutics positions in Q1 2023 and 19 closed out, a net change of -11 holders.
  • The largest Definium Therapeutics buyer in Q1 2023 was Two Sigma Investments, an estimated $447K added.
  • The largest Definium Therapeutics seller in Q1 2023 was Merit Financial Group, an estimated $1.19M sold.

Based on aggregated 13F filings for Q1 2023.